Relationship Between Sociodemographic, Clinic-laboratory And Genetic Variation With Aspirin Resistance in Chinese Cerebral Infarct Patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500098908

Enrollment

Unknown

Registered

2025-03-14

Start date

2024-09-01

Completion date

Unknown

Last updated

2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral infarction

Interventions

Group1:Aspirin sensitive group

:None

Group2:aspirin resistant group:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1?In accordance with the judgment criteria of "Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018" , There are clearly new lesions on head electronic computer tomography and nuclear magnetic resonance imaging; Within 7 days of onset of illness; 2?After admission and always regular aspirin (100 mg/day); 3?Sign the book told license.

Exclusion criteria

Exclusion criteria: 1?Aspirin allergy, asthma; 2?With severe liver disease and blood coagulation function disorder; 3?the platelet 300 x 10^9 / L; 4? Has a tendency to bleeding or ulcers; 5?Cardiac embolism is CI main cause; 6?Nearly two weeks has a history of trauma, hemorrhage, or surgery; 7? With hemorrhagic disease history; 8?Loss of visitors? adherence to claim.

Design outcomes

Primary

Measure	Time frame
Platelet endothelial aggregation receptor 1;Peroxide synthase within prostaglandins;	—

Countries

China

Contacts

Public ContactGAO YAN

Affiliated Hospital of beihua University

279991417@qq.com+86 432 62166403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026